IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE
SCREENING TEST FOR PRIMARY ALDOSTERONISM?

a 2019

IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM?

VACLAVIK, J.; M. KRISTKOVA; T. OPRSALOVA; Jiří JARKOVSKÝ; Klára BENEŠOVÁ et al.

Základní údaje

Originální název

IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM?

Autoři

VACLAVIK, J.; M. KRISTKOVA; T. OPRSALOVA; Jiří JARKOVSKÝ ; Klára BENEŠOVÁ; E. KOCIANOVA; M. KAMASOVA a L. JELINEK

Vydání

29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), 2019

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.171

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/19:00113709

Organizační jednotka

Přírodovědecká fakulta

ISSN

DOI

https://doi.org/10.1097/01.hjh.0000570672.73711.19

UT WoS

000481429700080

Klíčová slova anglicky

primary hyperaldosteronism

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 21. 4. 2020 15:52, Mgr. Marie Novosadová Šípková, DiS.

Anotace

V originále

Primary hyperaldosteronism (PHA) is one of the most common causes of secondary hypertension. The aim of this work was to evaluate whether confirmatory testing is necessary in all patients with a positive screening test.

Citovat

VACLAVIK, J.; M. KRISTKOVA; T. OPRSALOVA; Jiří JARKOVSKÝ; Klára BENEŠOVÁ; E. KOCIANOVA; M. KAMASOVA a L. JELINEK. IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM? In 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH). 2019. ISSN 0263-6352. Dostupné z: https://doi.org/10.1097/01.hjh.0000570672.73711.19.

@proceedings{1648042,
   author = {Vaclavik, J. and Kristkova, M. and Oprsalova, T. and Jarkovský, Jiří and Benešová, Klára and Kocianova, E. and Kamasova, M. and Jelinek, L.},
   booktitle = {29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH)},
   doi = {https://doi.org/10.1097/01.hjh.0000570672.73711.19},
   keywords = {primary hyperaldosteronism},
   language = {eng},
   title = {IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM?},
   url = {https://journals.lww.com/jhypertension/Abstract/2019/07001/IS_CONFIRMATORY_TESTING_NEEDED_IN_ALL_PATIENTS.79.aspx},
   year = {2019}
}

TY  - CONF
ID  - 1648042
AU  - Vaclavik, J. - Kristkova, M. - Oprsalova, T. - Jarkovský, Jiří - Benešová, Klára - Kocianova, E. - Kamasova, M. - Jelinek, L.
PY  - 2019
TI  - IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM?
KW  - primary hyperaldosteronism
UR  - https://journals.lww.com/jhypertension/Abstract/2019/07001/IS_CONFIRMATORY_TESTING_NEEDED_IN_ALL_PATIENTS.79.aspx
L2  - https://journals.lww.com/jhypertension/Abstract/2019/07001/IS_CONFIRMATORY_TESTING_NEEDED_IN_ALL_PATIENTS.79.aspx
N2  - Primary hyperaldosteronism (PHA) is one of the most common causes of secondary hypertension. The aim of this work was to evaluate whether confirmatory testing is necessary in all patients with a positive screening test.
ER  -

VACLAVIK, J.; M. KRISTKOVA; T. OPRSALOVA; Jiří JARKOVSKÝ; Klára BENEŠOVÁ; E. KOCIANOVA; M. KAMASOVA a L. JELINEK. IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM? In \textit{29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH)}. 2019. ISSN~0263-6352. Dostupné z: https://doi.org/10.1097/01.hjh.0000570672.73711.19.

Přehled o publikaci